Short-course (3-month) enzalutamide monotherapy in biochemically recurrent prostate cancer (BCR): Preliminary prostate specific membrane antigen tumor volume (PSMA-TV) data.Aanika Warner, Melissa Lauren Abel, Esther Mena et al.|Journal of Clinical Oncology|2026Cited by 0